Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00001335 Background | Apr 1993 → Jan 2002 | Ewing sarcoma, neuroblastoma, rhabdomyosarcoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001335 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human G-CSF” NCT00001335 ↗ |